Cheol Ung Choi Selected Research

Acetylcholine (Acetylcholine Chloride)

4/2018	Impact of Trimetazidine Treatment on 5-year Clinical Outcomes in Patients with Significant Coronary Artery Spasm: A Propensity Score Matching Study.
3/2018	Five-year major clinical outcomes according to severity of coronary artery spasm as assessed by intracoronary acetylcholine provocation test.
1/2018	The impact of myocardial bridge on coronary artery spasm and long-term clinical outcomes in patients without significant atherosclerotic stenosis.
1/2018	Impact of serum lipoprotein(a) on endothelium-dependent coronary vasomotor response assessed by intracoronary acetylcholine provocation.
1/2018	Impact of alcohol drinking on acetylcholine-induced coronary artery spasm in Korean populations.
1/2018	The association of chronic air pollutants with coronary artery spasm, vasospastic angina, and endothelial dysfunction.
7/2017	Three-year follow-up of patients with acetylcholine-induced coronary artery spasm combined with insignificant coronary stenosis.
1/2017	Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
1/2017	Impact of Diltiazem Alone versus Diltiazem with Nitrate on Five-Year Clinical Outcomes in Patients with Significant Coronary Artery Spasm.
1/2016	Impact of Renin-Angiotensin System Inhibitors on Long-Term Clinical Outcomes of Patients With Coronary Artery Spasm.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cheol Ung Choi Research Topics

Disease

41	Myocardial Infarction 07/2022 - 09/2007
28	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 04/2010
19	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2007
14	Coronary Vasospasm (Coronary Artery Vasospasm) 05/2022 - 11/2009
14	Thrombosis (Thrombus) 05/2022 - 09/2007
13	Diabetes Mellitus 01/2021 - 09/2012
12	Hypertension (High Blood Pressure) 01/2022 - 04/2009
11	Atrial Fibrillation 12/2020 - 04/2011
8	Chest Pain (Chest Pains) 01/2019 - 02/2007
8	Spasm (Spasms) 01/2017 - 10/2007
7	ST Elevation Myocardial Infarction 01/2022 - 04/2010
7	Stroke (Strokes) 09/2020 - 09/2016
6	Heart Failure 01/2022 - 01/2015
6	Death (Near-Death Experience) 12/2020 - 04/2010
3	Peripheral Arterial Disease 01/2021 - 11/2009
3	Hemorrhage 09/2020 - 02/2011
3	Insulin Resistance 01/2020 - 02/2013
3	Dyslipidemias (Dyslipidemia) 01/2020 - 06/2010
3	Pathologic Constriction (Stenosis) 03/2018 - 12/2012
3	Inflammation (Inflammations) 01/2018 - 04/2011
2	Non-ST Elevated Myocardial Infarction 01/2022 - 01/2012
2	Hematoma 01/2020 - 01/2018
2	Coronary Disease (Coronary Heart Disease) 01/2020 - 02/2007
2	Coronary Stenosis (Coronary Artery Stenosis) 01/2019 - 07/2017
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2018 - 01/2015
2	Infarction (Infarctions) 04/2018 - 05/2008
2	Cardiac Arrhythmias (Arrythmia) 06/2015 - 04/2011
2	Chronic Limb-Threatening Ischemia 04/2015 - 03/2015
2	Essential Hypertension 06/2013 - 10/2011
1	Arteritis 01/2021
1	Heart Diseases (Heart Disease) 01/2021
1	Sleep Apnea Syndromes (Sleep Apnea) 01/2020
1	Ischemic Stroke 01/2020
1	Heart Arrest (Cardiac Arrest) 11/2019
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2019
1	Angina Pectoris 01/2019
1	Prediabetic State (Prediabetes) 06/2018
1	Chronic Renal Insufficiency 01/2018
1	Vascular Diseases (Vascular Disease) 01/2018
1	Coronary Occlusion 09/2017

Drug/Important Bio-Agent (IBA)

24	omega-Chloroacetophenone (Mace)IBA 10/2021 - 01/2012
19	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2018 - 10/2007
10	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2010
7	Antihypertensive Agents (Antihypertensives)IBA 06/2020 - 04/2009
6	C-Reactive ProteinIBA 07/2019 - 05/2008
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 02/2007
4	LDL CholesterolIBA 01/2022 - 01/2010
4	Angiotensin Receptor AntagonistsIBA 01/2021 - 01/2016
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2016
4	Clopidogrel (Plavix)FDA Link 09/2020 - 02/2007
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2014 - 02/2007
4	Sirolimus (Rapamycin)FDA Link 10/2014 - 09/2007
3	Atorvastatin (Lipitor)FDA Link 01/2021 - 04/2015
3	oxidized low density lipoproteinIBA 01/2020 - 01/2010
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 06/2014
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 06/2019 - 01/2017
3	zotarolimusIBA 12/2016 - 12/2009
3	Everolimus FDA Link 12/2016 - 09/2012
3	Phenobarbital (Luminal)FDA Link 06/2014 - 11/2009
3	Heparin (Liquaemin)FDA LinkGeneric 01/2012 - 02/2007
2	CholesterolIBA 01/2022 - 01/2020
2	Uric Acid (Urate)IBA 01/2021 - 01/2018
2	Rosuvastatin Calcium (Crestor)FDA Link 01/2021 - 04/2019
2	Cilostazol (Pletal)FDA LinkGeneric 09/2020 - 09/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2019 - 07/2007
2	NitratesIBA 04/2018 - 01/2017
2	pitavastatin (itavastatin)FDA Link 01/2018 - 12/2011
2	Lipoprotein(a)IBA 01/2018 - 05/2008
2	Biomarkers (Surrogate Marker)IBA 11/2015 - 04/2011
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 12/2011
2	LipidsIBA 11/2013 - 09/2012
2	Enoxaparin (Lovenox)FDA LinkGeneric 01/2012 - 04/2010
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2012 - 04/2010
1	PolymersIBA 05/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	hydroxyethyl methacrylate (HEMA)IBA 01/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2020
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2020
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020
1	Meloxicam (Mobic)FDA LinkGeneric 01/2020
1	Celecoxib (Celebrex)FDA Link 01/2020
1	Hemoglobins (Hemoglobin)IBA 06/2018
1	Glucose (Dextrose)FDA LinkGeneric 06/2018
1	Parasympatholytics (Antispasmodics)IBA 04/2018
1	Trimetazidine (Vastarel)IBA 04/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Air Pollutants (Pollutants, Air)IBA 01/2018

Therapy/Procedure

31	Percutaneous Coronary Intervention 07/2022 - 09/2007
22	Drug-Eluting Stents 05/2022 - 02/2007
19	Stents 05/2022 - 02/2007
17	Therapeutics 01/2021 - 01/2010
9	Catheter Ablation 12/2020 - 04/2011
3	Surgical Amputation (Amputations) 01/2021 - 03/2015
2	Cardiac Rehabilitation 12/2021 - 01/2020
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2012 - 02/2007
1	Secondary Prevention 01/2021
1	Limb Salvage 01/2021